Evaluation of factors responsible for the inability of insulin to antagonize lipolysis due to high concentrations of catecholamines.
D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism*; D000818:Animals; D002395:Catecholamines / Q000502:physiology*; D000242:Cyclic AMP / Q000378:metabolism; D007328:Insulin / Q000494:pharmacology*; D007545:Isoproterenol / Q000494:pharmacology*; D019787:Linoleic Acid; D008041:Linoleic Acids / Q000494:pharmacology; D008066:Lipolysis / Q000187:drug effects*; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D012254:Ribavirin / Q000494:pharmacology; D012966:Sodium Cyanide / Q000494:pharmacology
D002395:Catecholamines; D007328:Insulin; D008041:Linoleic Acids; D012254:Ribavirin; D019787:Linoleic Acid; D000242:Cyclic AMP; D007545:Isoproterenol; D012966:Sodium Cyanide